Currently available GLP-1 receptor agonists in the UK include: For type 2 diabetes : semaglutide (Ozempic [injection], Rybelsus [oral tablet]), dulaglutide (Trulicity), liraglutide (Victoza), exenatide (Byetta, Bydureon), and lixisenatide (Lyxumia) For weight management : semaglutide 2.4 mg (Wegovy) and liraglutide 3 mg (Saxenda) Most GLP-1 medications are administered via subcutaneous injection, with dosing frequencies ranging from daily to once weekly depending on the specific formulation
Does GLP-1 medication itself damage skin, or is it just the rapid weight loss
The effects of GLP-1 and its analogs on energy expenditure are still inconsistent [48]
Robertson AGN, Wiggins T, Robertson FP, et al
Li M, Zhao S, Wu S, Yang X, Feng H
Some patients also notice an upset stomach, nausea, constipation, diarrhea, or a heavy, full feeling, especially at the beginning or with higher doses